series-c-plus
Stage
2018
Founded
1
Investors
About
LifeMine Therapeutics is a biopharmaceutical company that leverages a unique, genomically-enabled drug discovery platform to identify and develop novel therapeutic molecules from eukaryotic microbes, with an initial focus on fungi. The company uses its Avatar™ platform, which integrates genomics, data science, synthetic biology, and AI to unlock nature's evolutionary wisdom for drug candidates targeting high-impact disease areas such as cancer, immune disorders, and rare diseases.
Explore LifeMine Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.